Why is immunotherapy for glioblastoma "Lag"-ging

Research output: Contribution to journal › Editorial

Keywords

@article{75da35b10601450bb81ec8b7aced7e82,

title = "Why is immunotherapy for glioblastoma {"}Lag{"}-ging",

keywords = "Glioblastoma, LAG-3, PD-1",

author = "Dimitrios Mathios and Michael Lim",

year = "2019",

month = feb,

day = "1",

language = "English",

volume = "10",

pages = "1228--1229",

journal = "Oncotarget",

issn = "1949-2553",

number = "12",

}

TY - JOUR

T1 - Why is immunotherapy for glioblastoma "Lag"-ging

AU - Mathios, Dimitrios

AU - Lim, Michael

PY - 2019/2/1

Y1 - 2019/2/1

KW - Glioblastoma

KW - LAG-3

KW - PD-1

UR - https://www.scopus.com/pages/publications/85061386704

M3 - Editorial

C2 - 30815223

AN - SCOPUS:85061386704

SN - 1949-2553

VL - 10

SP - 1228

EP - 1229

JO - Oncotarget

JF - Oncotarget

IS - 12

ER -